NMT1 is necessary for lysosomal degradation and mTORC1 activation in cancer cells, and compounds targeting NMT1 may have therapeutic benefit in cancer by preventing mTORC1 activation and simultaneously blocking lysosomal degradation, leading to cancer cell death [44]. Here, NMT1 is linked to cancer.